OPC PHARMACEUTICAL JOINT-STOCK COMPANY

OPC Pharmaceutical Joint-Stock Company: A Trusted Leader in Vietnam’s Traditional Medicine Industry

OPC Pharmaceutical Joint-Stock Company (Công ty Cổ phần Dược phẩm OPC) is one of Vietnam’s most respected names in the production of traditional and herbal medicines. With decades of experience and a vertically integrated business model, OPC has positioned itself as a pioneering force in the modernization of traditional medicine. The company is officially registered under business ID and tax code 0301439462, and is publicly traded on the Ho Chi Minh Stock Exchange with the stock ticker OPC.

Headquartered at 1017 Hong Bang Street, Ward 12, District 6, Ho Chi Minh City, OPC operates as a joint stock company with both institutional and retail investors. Its leadership team includes experienced executives with strong pharmaceutical and scientific backgrounds, including the Board of Directors and a professional management team that guides the company’s production, distribution, and R&D strategies. OPC maintains GMP-WHO certified facilities and an extensive distribution network that covers hospitals, pharmacies, and retail chains throughout Vietnam.

In the fiscal year 2023, OPC Pharmaceutical reported revenue of USD 41.28 million and net profit of USD 5.03 million. The company’s total assets stood at USD 51.80 million, with owner’s equity of USD 36.32 million, reflecting a sound capital base and efficient resource management. Its relatively small scale compared to industry giants is offset by a focused product strategy, brand loyalty in traditional medicine, and consistent financial returns. OPC’s stable profit margins and low leverage make it an attractive model for sustainable pharmaceutical operations.

OPC specializes in herbal and OTC products rooted in Vietnam’s rich pharmacopoeia. Its flagship remedies for respiratory, digestive, and immune health have earned the trust of generations. The company also invests in research to clinically validate traditional formulations, ensuring both scientific rigor and market compliance. As health consumers in Vietnam shift toward natural therapies and preventive care, OPC is well positioned to lead this transformation.

For businesses, researchers, and investors seeking validated information on Vietnam’s pharmaceutical sector, Vanguard Business Information LLC (VBI) provides detailed financial reports, risk metrics, and operational insights into companies like OPC. With a long-standing legacy, effective governance, and a deep commitment to traditional healing, OPC continues to play a vital role in Vietnam’s healthcare ecosystem.